Targeting IL-34 in chronic inflammation
Open Access
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 19 (8) , 1212-1216
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Transcriptional profiling and pathway analysis of CSF-1 and IL-34 effects on human monocyte differentiationCytokine, 2013
- Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of MicrogliaImmunity, 2012
- The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturationDevelopmental Biology, 2012
- IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microgliaNature Immunology, 2012
- The Critical Role of IL-34 in OsteoclastogenesisPLOS ONE, 2011
- Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cellsJournal of Leukocyte Biology, 2010
- IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activationCell Death & Differentiation, 2010
- Interleukin‐34 is expressed by giant cell tumours of bone and plays a key role in RANKL‐induced osteoclastogenesisThe Journal of Pathology, 2010
- Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular ProteomeScience, 2008
- Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defectsBlood, 2002